Can you get a Tdap vaccine while on Cosentyx (secukinumab)?
Yes. Tdap vaccination is generally allowed for people taking Cosentyx (secukinumab), because Tdap is a non-live (inactivated/toxoid) vaccine. Cosentyx is an immunomodulating biologic that targets IL‑17A, but it does not make non-live vaccines the same kind of concern as live vaccines.
What’s the key rule about live vs. non-live vaccines on Cosentyx?
The main safety concern with biologics like Cosentyx is usually with live vaccines. Tdap is not a live vaccine, so it does not fall under the typical “avoid live vaccines while immunosuppressed” guidance used for drugs that affect immune function.
What do clinicians typically do if someone needs Tdap urgently?
Clinicians generally vaccinate with Tdap when it’s needed for protection (for routine boosters or wound-related situations) as long as the vaccine is non-live and there isn’t another contraindication specific to the patient (for example, a previous severe allergic reaction to a vaccine component).
Are there extra precautions or timing considerations?
There are usually no special “stop Cosentyx for Tdap” steps required for non-live vaccines. If you are planning multiple vaccines or you’re getting vaccinated around the time of an infection or other medical issues, your prescribing clinician or pharmacist can help coordinate timing.
What if you meant a different tetanus shot (Td vs Tdap) or tetanus after a wound?
The safety logic is the same for Td and Tdap because they are also non-live vaccines. The urgency after a wound usually depends on the wound type and your prior tetanus immunization history; clinicians then decide whether you need Tdap and/or tetanus immune globulin.
What should you tell your doctor or pharmacist before getting Tdap?
Tell them you take Cosentyx, your last tetanus vaccine date (if known), and whether you’ve ever had a severe allergic reaction to any vaccine. Also mention any recent serious infection or current symptoms, since that can affect vaccination timing even when the vaccine is non-live.
Sources
No DrugPatentWatch.com sources were used, because this question is about vaccine administration guidance rather than drug patent/exclusivity information.